Mirador Capital Partners LP Reduces Position in The Cooper Companies, Inc. (NASDAQ:COO)

Mirador Capital Partners LP lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,360 shares of the medical device company’s stock after selling 451 shares during the quarter. Mirador Capital Partners LP’s holdings in Cooper Companies were worth $1,228,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of COO. Ashton Thomas Securities LLC purchased a new position in shares of Cooper Companies during the 3rd quarter valued at $25,000. Covestor Ltd lifted its stake in shares of Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares in the last quarter. Brown Brothers Harriman & Co. lifted its stake in shares of Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after buying an additional 275 shares in the last quarter. Friedenthal Financial bought a new stake in Cooper Companies in the 3rd quarter valued at $50,000. Finally, Cromwell Holdings LLC bought a new stake in Cooper Companies in the 3rd quarter valued at $52,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.4 %

NASDAQ:COO opened at $91.00 on Thursday. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38. The firm has a 50 day moving average of $96.98 and a 200 day moving average of $98.89. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $18.16 billion, a price-to-earnings ratio of 46.67, a PEG ratio of 2.29 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the prior year, the company posted $0.87 earnings per share. Cooper Companies’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Citigroup reduced their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Wells Fargo & Company boosted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Morgan Stanley reduced their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Finally, StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.